Background and study aims: Sedation with propofol is associated with a high acceptance rate in upper gastrointestinal
endoscopy. So far, however, there are no valid data on whether the use of propofol
can increase the general quality of the endoscopic examination.
Patients and methods: A total of 60 patients referred for upper gastrointestinal endoscopy were randomized
to receive sedation with either midazolam (n = 30) or propofol (n = 30). The maximum
dosages permitted were 5 mg of midazolam and 500 mg of propofol. The examinations
were recorded on videotapes, and the quality of upper endoscopy was assessed by videotape
analysis by three experienced endoscopists who were all blinded to patient data and
the medications used for sedation. A score sheet was used with 18 assessment items
that each represented a step of upper gastrointestinal endoscopy and a global score
for the entire examination. A scale ranging from 1 (excellent) to 6 (very poor) was
used. Data were analyzed on an intention-to-investigate basis: inability to perform
the procedure because of a patient’s intolerance of the procedure, for example, was
scored as 6 (i. e. very poor).
Results: Patients in the two groups were well matched with respect to demographic and clinical
data. Four patients in the midazolam group could not be adequately examined. The median
dosage used for sedation was 5 mg midazolam (range 2 - 5 mg) and 160 mg propofol (range
70 - 320 mg). When assessments by all three blinded examiners were added together,
propofol sedation was found to result in significantly better scores for all parameters
except for the assessments of “Z-line/cardia”, “duodenal bulb”, and “duodenal folds”
(all P < 0.05, Mann-Whitney U test).
Conclusion: Sedation with propofol might increase the quality of upper endoscopy. This finding
may have a significant impact on the selection of the type of sedation, not only in
terms of increasing patients’ acceptance of the procedure, but also for improving
the diagnostic accuracy of upper gastrointestinal endoscopy.
References
1
Abraham N, Fallone C A, Mayrand S. et al .
Sedation versus no sedation in the performance of diagnostic upper gastrointestinal
endoscopy: a Canadian randomized controlled cost-outcome study.
Am J Gastroenterol.
2004;
99
1692-1699
2
Faulx A L, Vela S, Das A. et al .
The changing landscape of practice patterns regarding unsedated endoscopy and propofol
use: a national web survey.
Gastrointest Endosc.
2005;
62
993
3
Ristikankare M, Kartikainen J, Heikkinen M, Julkunen R.
Is routine sedation or topical pharyngeal anesthesia beneficial during upper endoscopy?.
Gastrointest Endosc.
2004;
60
686-694
4
Lazzaroni M, Bianchi Porro G.
Preparation, premedication and surveillance.
Endoscopy.
2003;
35
103-111
5
Heuss L T, Froehlich F, Beglinger C.
Changing patterns of sedation and monitoring practice during endoscopy: results of
a nationwide survey in Switzerland.
Endoscopy.
2005;
37
161-166
6
Jung M, Hofmann C, Kiesslich R, Brackertz A.
Improved sedation in diagnostic and therapeutic ERCP: propofol is an alternative to
midazolam.
Endoscopy.
2000;
32
233-238
7
Hofmann C, Kiesslich R, Brackertz A, Jung M.
Propofol for sedation in gastroscopy: a randomized comparison with midazolam.
Z Gastroenterol.
1999;
37
589-595
8
Riphaus A, Stergiou N, Wehrmann T.
Sedation with propofol for routine ERCP in high-risk octogenarians: a randomized,
controlled study.
Am J Gastroenterol.
2005;
100
1957-1963
9
Carlsson U, Grattidge P.
Sedation for upper gastrointestinal endoscopy: a comparative study of propofol and
midazolam.
Endoscopy.
1995;
27
240-243
10
Krugliak P, Ziff B, Rusabrov Y. et al .
Propofol versus midazolam for conscious sedation guided by processed EEG during endoscopic
retrograde cholangiopancreatography: a prospective, randomized, double-blind study.
Endoscopy.
2000;
32
677-682
11
Chen W X, Lin H J, Zhang W F. et al .
Sedation and safety of propofol for therapeutic endoscopic retrograde cholangiopancreatography.
Hepatobiliary Pancreat Dis Int.
2005;
4
437-440
12
Byrne M F, Baillie J.
Nurse-assisted propofol sedation: the jury is in!.
Gastroenterology.
2005;
129
1781-1792
13
Kulling D, Rothenbuhler R, Inauen W.
Safety of nonanesthesist sedation with propofol for outpatient colonoscopy and esophagogastroduodenoscopy.
Endoscopy.
2003;
35
679-682
14
Saenz-Lopez S, Rodriguez Munoz S, Rodriguez-Alcalde D. et al .
Endoscopist controlled administration of propofol: an effective and safe method of
sedation in endoscopic procedures.
Rev Esp Enferm Dig.
2006;
98
25-35
15
Rex D K, Heuss L T, Walker J A, Qi R.
Trained registered nurses/endoscopy teams can administer propofol safely for endoscopy.
Gastroenterology.
2005;
129
1384-1391
16
American Society for Gastrointestinal Endoscopy .
Guidelines for conscious sedation and monitoring during gastrointestinal endoscopy.
Gastrointest Endosc.
2003;
58
317-322
17 Hofmann C, Jung M. Sedierung und Überwachung bei endoskopischen Eingriffen. Guidelines
of the endoscopic section of the German Society for Digestive and Metabolic Diseases. Available from: http://www.dgvs.de/media/1.2.Sedierung-ueberwachung.pdf
18
Neumann M, Friedl S, Meining A. et al .
A score card for upper gastrointestinal endoscopy: evaluation of interobserver variability
in examiners with various levels of experience.
Z Gastroenterol.
2002;
40
857-862
19
Ulmer B J, Hansen J J, Overley C A. et al .
Propofol versus midazolam/fentanyl for outpatient colonoscopy: administration by nurses
supervised by endoscopists.
Clin Gastroenterol Hepatol.
2003;
1
425-432
20
Qadeer M A, Vargo J J, Khandwala F. et al .
Propofol versus traditional sedative agents for gastrointestinal endoscopy: a meta-analysis.
Clin Gastroenterol Hepatol.
2005;
3
1049-1056
21
Yusoff I F, Raymond G, Sahai A V.
Endoscopist administered propofol for upper gastrointestinal EUS is safe and effective:
a prospective study in 500 patients.
Gastrointest Endosc.
2004;
60
356-360
A. Meining, MD
Medizinische Klinik II
Technical University of Munich
Klinikum rechts der Isar
Ismaningerstr. 22
D-81675 Munich
Germany
Fax: +49-89-4140-4905
Email: alexander.meining@lrz.tum.de